Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy

NCT: NCT03194971 · COMPLETED

NCT IDNCT03194971

StatusCOMPLETED

Start Date2017-06-01

Completion2023-06-04

Brief Summary

This study will assess whole brain samples from glioblastoma patients at autopsy to determine the underlying pathological signatures of tumor treatment fields at autopsy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑